002365SZSE

Announcement of Resolutions of the 15th Meeting of the 7th Board of Directors

✨ AI Summary

This announcement details the resolutions passed at the 15th meeting of the 7th Board of Directors of Qianjiang Yong'an Pharmaceutical Co., Ltd. Key decisions include approving the Q1 2026 report, authorizing the use of up to RMB 700 million in idle funds for wealth management, amending the company's business scope and articles of association, and scheduling the 2025 Annual General Meeting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002365 Securities Abbreviation: Yong'an Pharmaceutical Announcement No.: 2026-22

Qianjiang Yong'an Pharmaceutical Co., Ltd. Announcement of Resolutions of the 15th Meeting of the 7th Board of Directors

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or significant omissions.

The notice for the 15th meeting of the 7th Board of Directors of Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was delivered to all directors in written, telephone, and email formats on April 17, 2026. The meeting was held via teleconference in the Company's meeting room on April 29, 2026. A total of 7 directors were eligible to vote, and 7 directors actually participated in the voting. The convocation and convening of this meeting comply with the provisions of the "Company Law" and the "Articles of Association." The meeting voted on each item by written ballot, and the following resolutions were passed:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.